Nurse Practitioner, Psychiatric/Mental Health · Cleveland, MS
NPI
1740791722
Since 2017
Specialty
Nurse Practitioner, Psychiatric/Mental Health
Code 363LP0808X
Group practices
8
Medicare group memberships
Hospitals
0
Hospital affiliations
714 3rd St
Cleveland, MS, 38732
Phone (662) 846-2620
Groups this clinician bills Medicare through
Medicare paid, 2024
$67K
1,482 services
Medicare patients, 2024
341
Average age 67
Drug cost, 2024
$2.9M
8,975 prescriptions
Company payments, 2025
$16K
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Lawanda Glass was code 99232 (hospital e&m - subsequent), 635 times for 139 patients. In total Lawanda Glass billed 1,482 services in 11 codes, and Medicare paid $67K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-07-16.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 635 | 139 | $48.72 | $31K |
| 99213 Office E&M - Established | Office | 378 | 151 | $41.50 | $16K |
| 96372 Injection Administration | Office | 165 | 56 | $7.40 | $1,220 |
| 99232 Hospital E&M - Subsequent | Office | 126 | 24 | $46.38 | $5,844 |
| 99215 Office E&M - Established | Office | 63 | 57 | $95.01 | $5,986 |
| 90792 Psychotherapy - Nongroup | Office | 56 | 52 | $52.54 | $2,942 |
| 99222 Hospital E&M - Initial | Facility | 39 | 38 | $78.58 | $3,065 |
| 99239 Hospital Discharge Management | Facility | 12 | 12 | $71.07 | $853 |
By year: 2022 $41K for 895 services; 2023 $104K for 2,215 services; 2024 $67K for 1,482 services.
Medicare prescription drug claims, 2024
In 2024, the drug Lawanda Glass prescribed most often to Medicare patients was Benztropine Mesylate, with 990 prescriptions and refills. In total Lawanda Glass wrote 8,975 Medicare prescriptions that cost $2.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Benztropine Mesylate Generic | 990 | 1,095 | 235 | $10K |
| Trazodone Hcl Generic | 807 | 873 | 218 | $11K |
| Risperidone Generic | 508 | 567 | 131 | $4,707 |
| Quetiapine Fumarate Generic | 413 | 471 | 114 | $8,017 |
| Haloperidol Generic | 358 | 391 | 83 | $10K |
| Haloperidol Decanoate Generic | 358 | 358 | 78 | $17K |
| Citalopram Hbr Citalopram Hydrobromide | 301 | 321 | 68 | $3,113 |
| Divalproex Sodium Generic | 286 | 301 | 71 | $5,322 |
| Invega Sustenna Paliperidone Palmitate | 284 | 284 | 68 | $824K |
| Hydroxyzine Pamoate Generic | 262 | 283 | 84 | $3,416 |
| Sertraline Hcl Generic | 260 | 289 | 86 | $3,003 |
| Divalproex Sodium Er Divalproex Sodium | 250 | 265 | 55 | $13K |
| Olanzapine Generic | 246 | 258 | 61 | $6,307 |
| Fluoxetine Hcl Generic | 244 | 301 | 66 | $3,288 |
| Hydroxyzine Hcl Generic | 237 | 261 | 68 | $5,796 |
Brand drugs: 749 claims; generic drugs: 8,226 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Lawanda Glass $16K ($16K in general payments such as food, travel and fees) from 9 companies. The largest payer was Teva Pharmaceuticals USA, Inc. with $14K.
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. TEVA | 45 | $14K |
| Neurocrine BioSciences, Inc. NBIX | 42 | $530 |
| Vanda Pharmaceuticals Inc. VNDA | 24 | $404 |
| Alkermes, Inc. ALKS | 14 | $302 |
| Abbvie Inc. ABBV | 13 | $225 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 9 | $141 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 5 | $97.71 |
| Janssen Pharmaceuticals, Inc JNJ | 4 | $87.77 |
| E.R. Squibb & Sons, L.L.C. BMY | 2 | $35.29 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.